Beverly Dale Jolly and Brenda Rice Jolly, Respondents, v. General Electric Company, et al., Defendants, Of whom Fisher Controls International LLC and Crosby Valve, LLC are the Appellants.
Appellate Case No. 2017-002611
THE STATE OF SOUTH CAROLINA In The Court of Appeals
Filed September 1, 2021
Appeal From Spartanburg County Jean Hoefer Toal, Acting Circuit Court Judge Opinion No. 5858 Heard November 2, 2020
AFFIRMED
C. Mitchell Brown, Allen Mattison Bogan, James Bruce Glenn, and Nicholas Andrew Charles, all of Nelson Mullins Riley & Scarborough, LLP, of Columbia, for Appellants.
Theile Branham McVey and John D. Kassel, both of Kassel McVey, of Columbia; and Lisa White Shirley and Jonathan Marshall Holder, both of Dean Omar Branham Shirley, LLP, of Dallas, Texas, all for Respondents.
FACTS/PROCEDURAL HISTORY
From early 1980 to late 1984, Dale worked as a mechanical inspector for Duke Power Company (Duke) at the Oconee, McGuire, and Catawba nuclear power plants in South Carolina and North Carolina.1 During this time, his duties regularly brought him within close proximity to his co-workers’ removal of asbestos gaskets from valves supplied by various manufacturers,2 including Appellants. Appellant Fisher Controls International
Dale was so close to the process of removing the worn gaskets that he saw and breathed in the dust being released from the brushing and grinding of the gaskets,4 and he wore safety goggles to keep the dust out of his eyes. Although Appellants manufactured only the valves and not the gaskets used with these valves, Appellants kept the gaskets in stock and sold them to Duke upon receiving Duke‘s purchase orders and specifications.
In late 1984, Dale left his position as a mechanical inspector and, except for a two-month break in 2002, continued to work for Duke in other capacities until December 2015, when he was diagnosed with mesothelioma, a type of lung cancer. After his diagnosis, Dale underwent extensive treatment for his condition, including several rounds of chemotherapy, a complicated surgery, a subsequent hospitalization, and experimental immunotherapy.
On April 25, 2016, Dale and his wife, Brenda, filed the present products liability action against Appellants and numerous co-defendants, alleging that Dale was exposed to asbestos emanating from the defendants’ products. Respondents asserted causes of action for, inter alia, negligence, strict
In July 2017, the circuit court conducted a trial on Respondents’ claims against Appellants. At the conclusion of the trial, the jury awarded $200,000 in actual damages to Dale for his negligence and breach of warranty claims and $100,000 in actual damages to Brenda for her loss of consortium claim. The circuit court later granted Respondents’ motion for a new trial nisi additur and increased Dale‘s award to $1,580,000 and Brenda‘s award to $290,000.
The circuit court also granted, in part, Appellants’ motion for a setoff of Respondents’ pre-trial settlement proceeds against the increased verdicts for Dale and Brenda. The circuit court accepted Respondents’ stated allocation of the proceeds, which assigned one-third to Dale‘s claims; one-third to Brenda‘s claims; and one-third for a future wrongful death claim. As to the portion of proceeds Respondents had allocated to a future wrongful death claim, the circuit court denied setoff. The circuit court also denied Appellants’ motion for a JNOV and issued a separate written order memorializing its pre-trial denial of Appellants’ motion to quash Respondents’ trial subpoenas. Appellants later filed a motion for reconsideration, which the circuit court denied. This appeal followed.
LAW/ANALYSIS
I. Directed Verdict/JNOV
Appellants challenge the circuit court‘s denial of their motion for a JNOV on the following grounds: (1) there was no
A motion for a JNOV is “merely a renewal of [a] directed verdict motion.” RFT Mgmt. Co. v. Tinsley & Adams L.L.P., 399 S.C. 322, 331, 732 S.E.2d 166, 171 (2012). “When ruling on a JNOV motion, the [circuit] court is required to view the evidence and the inferences that reasonably can be drawn therefrom in the light most favorable to the nonmoving party.” Williams Carpet Contractors, Inc. v. Skelly, 400 S.C. 320, 325, 734 S.E.2d 177, 180 (Ct. App. 2012). “This court must follow the same standard.” Id. “If more than one reasonable inference can be drawn or if the inferences to be drawn from the evidence are in doubt, the case should be submitted to the jury.” Id. (quoting Chaney v. Burgess, 246 S.C. 261, 266, 143 S.E.2d 521, 523 (1965)).
“In considering a JNOV, the [circuit court] is concerned with the existence of evidence, not its weight,” and “neither [an appellate] court, nor the [circuit] court has authority to decide credibility issues or to resolve conflicts in the testimony or the evidence.” Curcio v. Caterpillar, Inc., 355 S.C. 316, 320, 585 S.E.2d 272, 274 (2003) (second alteration in original) (quoting Reiland v. Southland Equip. Serv., Inc., 330 S.C. 617, 634, 500 S.E.2d 145, 154 (Ct. App. 1998), abrogated on other grounds by Webb v. CSX Transp., Inc., 364 S.C. 639, 615 S.E.2d 440 (2005)). “The jury‘s verdict must be upheld unless no evidence reasonably supports the jury‘s findings.” Id. In other words, a motion for a JNOV “may be granted only if no reasonable jury could have reached the challenged verdict.” Gastineau v. Murphy, 331 S.C. 565, 568, 503 S.E.2d 712, 713 (1998).
A. Proximate Cause
Appellants maintain there was no evidence that Dale‘s exposure to asbestos from their products proximately caused
Whether the theory under which a products liability plaintiff seeks recovery is negligence, strict liability, or breach of warranty, it is necessary to show “the product defect was the proximate cause of the injury sustained.” Bray v. Marathon Corp., 356 S.C. 111, 116, 588 S.E.2d 93, 95 (2003).5 “Proximate cause requires proof of both causation in fact and legal cause, which is proved by establishing foreseeability.” Bray, 356 S.C. at 116–17, 588 S.E.2d at 95. “Ordinarily, the
question of proximate cause is one of fact for the jury[,] and the [circuit court‘s] sole function regarding the issue is to inquire whether particular conclusions are the only reasonable inferences that can be drawn from the evidence.” Small, 329 S.C. at 464, 494 S.E.2d at 843.
Further, “[t]o establish medical causation in a product liability case, a plaintiff must show both general causation and specific causation.” Fisher v. Pelstring, 817 F. Supp. 2d 791, 814 (D.S.C. 2011) (quoting In re Bausch & Lomb Inc. Contacts Lens Solution Prods. Liab. Litig., 693 F. Supp. 2d 515, 518 (D.S.C. 2010)). “General causation is whether a substance is capable of causing a particular injury or condition in the general population, while specific causation is whether a substance caused a particular individual‘s injury.” Id. (quoting In re Bausch & Lomb, 693 F. Supp. 2d at 518); see also David E. Bernstein, Getting to Causation in Toxic Tort Cases, 74 BROOK. L. REV. 51, 52 (2008). General causation “is generally not an issue in asbestos litigation” due to the parties’ acknowledgment that exposure to asbestos causes mesothelioma. Tort Law — Expert Testimony in Asbestos Litigation — District of South Carolina Holds the Every Exposure Theory Insufficient to Demonstrate Specific Causation Even If Legal Conclusions Are Scientifically Sound. — Haskins v. 3M Co. (hereinafter Asbestos Litigation), 131 HARV. L. REV. 658, 658 n.4 (2017). However, to show specific causation,
a claimant must do more than simply introduce into evidence epidemiological studies that show a substantially elevated risk. A claimant must show that he or she is similar to those in the studies. This would include proof that the injured person was exposed to the same substance, that the exposure or dose levels were comparable to or greater than those in the studies, that the exposure occurred before the onset of injury, and that the timing of the onset of injury was consistent with that experienced by those in the study.
Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 720 (Tex. 1997).
Moreover, when there are multiple possible sources of the plaintiff‘s exposure to a toxin, as in the present case, the plaintiff must also show that his exposure to a particular defendant‘s product was a “substantial factor” in the development of the plaintiff‘s disease. See Bernstein, 74 BROOK. L. REV. at 52 (“[W]ith regard to cases in which a plaintiff alleges injury after exposure to a toxin from multiple sources, a given defendant may only be held liable if the plaintiff proves by a preponderance of the evidence that exposure to that defendant‘s products was a ‘substantial factor’ in causing that injury.“). South Carolina has adopted the substantial factor test:
In determining whether exposure is actionable, we adopt the “frequency, regularity, and proximity test” set forth in Lohrmann v. Pittsburgh Corning Corp., 782 F.2d 1156, 1162[–63] (4th Cir. 1986): “To support a reasonable inference of substantial causation from circumstantial evidence, there must be evidence of exposure to a specific product on a regular basis over some extended period of time in proximity to where the plaintiff actually worked.”
Henderson v. Allied Signal, Inc., 373 S.C. 179, 185, 644 S.E.2d 724, 727 (2007) (emphases added); see also Lohrmann, 782 F.2d at 1158, 1162 (applying Maryland law to a pipefitter‘s products liability claims and restating Maryland‘s substantial factor test: “To establish proximate causation in Maryland, the plaintiff must introduce evidence [that] allows the jury to reasonably conclude that it is more likely than not that the conduct of the defendant was a substantial factor in bringing about the result.” (emphasis added)).6 While the substantial factor test relaxes the “but-for” requirement of traditional tort cases,7 it still requires the plaintiff to show “more than a casual or minimum contact with the product.” Lohrmann, 782 F.2d at 1162.8
The evidence in the present case satisfies general causation, specific causation, and the substantial factor test. At trial, Dale testified that during his four years as a mechanical
This work occurred at the Oconee, McGuire, and Catawba power stations whenever each respective station would shut down its operations to change out the uranium core and perform system maintenance. Each plant had at least one shutdown per year, and each shutdown would last approximately ten to twelve weeks. Dale was so close to the removal process that he saw and breathed in the dust being released from the brushing and grinding of the gaskets, and he wore safety goggles to keep the dust out of his eyes. Some of the valves were so large that the flange opening was tall enough for a person to fit in, and the removal process was time-consuming. David Taylor, Dale‘s co-worker, testified that there were hundreds of these valves at the Oconee plant.
Although Appellants manufactured only the valves and not the gaskets used with these valves, Appellants kept the gaskets in stock and sold them to Duke upon receiving Duke‘s purchase orders and specifications. See supra n.5. A major component of many of these gaskets, as well as replacement gaskets supplied by Appellants, was asbestos.
Appellants maintain that they sold to Duke only internal gaskets rather than “flange gaskets,” implying that Dale‘s work around gasket removals was limited to only those flanges connecting the valve to a pipe. However, the evidence shows at least some of Appellants’ valves had internal flanges that required a gasket. Therefore, the term “flange gasket” should encompass these internal gaskets that Appellants undoubtedly sold to Duke. Appellants also maintain that Dale‘s testimony regarding his exposure did not include these internal gaskets. However, Dale testified that his duties included inspecting the
The evidence summarized above, by itself, meets Henderson‘s substantial factor test.10 In a nutshell, Dale testified that during his four years as a mechanical inspector, he regularly and consistently worked in close proximity to co-workers removing asbestos gaskets from a “good many” Crosby valves and “[a] lot of” Fisher valves and that he breathed the dust, which was visible.11 Additionally, the expert testimony is sufficient to show both general and specific medical causation. Respondents presented the testimony of Dr. Arthur Frank, a physician specializing in occupational medicine;12 Dr.
Critically, Dr. Frank stated in his affidavit that his opinions were his “medical and scientific opinions” and that he was “not offering legal opinions about whether an exposure is ‘significant’ or ‘substantial’ within the meaning of the law.” Dr. Frank also stated, “Evaluation of all available human data provides no evidence for a threshold or for a ‘safe’ level of asbestos exposure,” and “[t]here is overwhelming, generally accepted evidence that inhalation of asbestos fibers of any type, from any source or product, causes mesothelioma.”13 Dr. Frank noted that the median latency period for malignant pleural mesothelioma, with which Dale was diagnosed, is 44.6 years among males.
Dr. Frank also noted that this particular illness is “an aggressive cancer of the membranes lining the lungs” and cited a study recognizing that all forms of asbestos cause mesothelioma. He also offered his scientific opinion that every “occupational, para-occupational, environmental or domestic exposure contributes to the risk of developing mesothelioma” and the cumulative exposure to asbestos contributes to the total dose of asbestos. Dr. Frank explained at trial that “cumulative exposure” means the likelihood of contracting cancer rises with increasing amounts of exposure. Dr. Frank
After having reviewed Dale‘s deposition testimony, his medical records, and other case documents, Dr. Frank testified at trial that the body of literature about the level of asbestos emitted when asbestos flange gaskets are removed from a valve indicates that significant levels of asbestos fibers are released when the gasket is removed using a hand wire brush or an electric-powered grinder. He explained that a significant level of asbestos fibers that can cause disease cannot be seen with the naked eye, and therefore, if one can see dust emanating from an asbestos product, the level is “potentially very high,” depending on the percentage of asbestos in the product. Given Dale‘s testimony that he saw dust emitted from the removal of gaskets, Dr. Frank stated the level of asbestos fibers to which Dale was exposed could have been very high. Dr. Frank quantified this type of exposure by comparing it to the background or ambient (non-workplace) exposure in urban areas, concluding that Dale‘s exposure to the removal of one gasket for a short period of time would have been in the range of 1 to 99 fibers per cubic centimeter, millions of times higher than background exposure.
Dr. Frank further testified that even the current permissible exposure limit of one-tenth of one fiber per cubic centimeter over the course of a year presents a cancer risk. According to Dr. Frank, some countries allow no exposure, and although rare, a single day of exposure to asbestos has been documented in epidemiological data as causing a person to contract mesothelioma. He also stated that a month or less of exposure has been documented as doubling the risk of lung cancer. Dr. Frank concluded that during Dale‘s four years working as a mechanical inspector for Duke, his regular and frequent exposures, from a distance of ten feet or less, to the removal of
Dr. John Maddox, a pathologist who has diagnosed over 500 patients with mesothelioma, cited studies establishing that even individuals in the lowest exposure category can develop mesothelioma after asbestos exposure. He also cited a study indicating that individuals in high-exposure occupations had shorter latency periods than those in occupations with lower exposures, citing mean latency periods for the high-exposure occupations of insulators and shipyard workers as 29.6 years and 35.4 years, respectively. In comparison, Dale‘s latency period was 31 years, as he was diagnosed with mesothelioma in 2015, thirty-one years after his last exposure to the asbestos gaskets sold by Appellants in late 1984.
After examining Dale‘s pathology records, Dr. Maddox determined that Dale had a right pleural malignant mesothelioma, epithelioid type. Dr. Maddox concluded that Dale‘s mesothelioma was caused by his cumulative asbestos exposure throughout his life. Dr. Maddox was asked to give his opinion on whether Dale‘s asbestos exposures from 1980 to 1984 caused his mesothelioma based on the following assumptions: (1) over the course of “three to four years,” Dale‘s exposures “came from asbestos-containing gaskets and packing used in some but not all of the valves at a power plant during outages . . . at several plants“; (2) as a regular part of his job, Dale was close enough to see the dust created by the removal of these gaskets, “often working one to two feet from” this process; and (3) the level of each of these exposures was hundreds of thousands of times higher than background levels. Dr. Maddox testified these exposures were significant, repetitive, high enough to provide visible dust, and within a reasonable latency period, which is at least ten years. Dr. Maddox stated that those exposures would be “sufficient to deem that causative.” Subsequently, Dr. Maddox was asked to assume that of those exposures, Dale had “multiple exposures . . . from [Appellants‘] valves in addition to several other companies’ equipment.” Based on this assumption, Dr. Maddox
Dr. Arnold Brody, a cell biologist, testified concerning how the inhalation of asbestos causes mesothelioma. Dr. Brody explained that there is a consensus in the scientific community that all of the commercial varieties of asbestos fibers “cause all of the asbestos diseases.” He also explained that whether an individual develops a disease from his or her exposure depends on the dose and that individual‘s personal susceptibility based on the response of his or her genetic defenses, and for mesothelioma, there is no known threshold or level above background levels that is known to be “safe or [that] will not cause mesothelioma.”
In sum, the above evidence showed that human inhalation of asbestos fibers of any type can cause mesothelioma, establishing general causation.14 This evidence also showed that (1) Dale worked in closed proximity to the asbestos released from
gaskets sold by Appellants; (2) these exposures, each one being at least 1 to 99 fibers per cubic centimeter per gasket (millions of times higher than background exposure), occurred on a regular basis for an extended period of time, 1980 to 1984; (3) even the current permissible exposure limit of one-tenth of one fiber per cubic centimeter over the course of a year presents a cancer risk; (4) Dale‘s latency period was 31 years; (5) the median latency period for malignant pleural mesothelioma, with which Dale was diagnosed, is 44.6 years among males; and (6) Dr. Maddox found the latency period for Dale‘s development of mesothelioma after exposure to Appellants’ gaskets to be reasonable. Therefore, this evidence also established specific causation and satisfied the elements of the substantial factor test.15
The “each and every exposure” theory espouses the view that “‘each and every breath’ of asbestos is substantially causative of mesothelioma.” See Rost, 151 A.3d at 1044 (“[E]xpert testimony based upon the notion that ‘each and every breath’ of
asbestos is substantially causative of mesothelioma will not suffice to create a jury question on the issue of substantial factor causation.“); Betz v. Pneumo Abex, LLC, 44 A.3d 27, 31 (Pa. 2012) (noting the report of plaintiffs’ causation expert concluded that each exposure is “a substantial contributing factor in the development of the disease that actually occurs” and did not assess the plaintiffs’ individual exposure history “as this was thought to be unnecessary, given the breadth of the any-exposure theory” (emphasis removed)); see also Yates v. Ford Motor Co., 113 F. Supp. 3d 841, 846 (E.D.N.C. 2015) (“Also referred to as ‘any exposure’ theory, or ‘single fiber’ theory, it represents the viewpoint that, because science has failed to establish that any specific dosage of asbestos causes injury, every exposure to
Respondents distinguish between the “each and every exposure” theory and the cumulative dose theory. They maintain that their experts relied on the cumulative dose theory and that their reliance on basic science in reaching their opinion is not the equivalent of testifying that “each and every exposure” was a substantial factor in causing Dale‘s mesothelioma. We agree. Respondents explain, “Even though the experts testified that all exposures contribute to the cumulative dose that causes disease, that does not mean that every exposure rises to the level of a substantial factor.” (first emphasis added). Respondents note that this distinction was also made in Rost, a case in which Dr. Frank testified.
In Rost, the Supreme Court of Pennsylvania concluded,
We must agree with the Rosts that Ford has confused or conflated the “irrefutable scientific fact” that every exposure cumulatively contributes to the total dose (which in turn increases the likelihood of disease), with the legal question under Pennsylvania law as to whether particular exposures to asbestos are “substantial factors” in causing the disease. It was certainly not this [c]ourt‘s intention, in [its precedent], to preclude expert witnesses from
informing juries about certain fundamental scientific facts necessary to a clear understanding of the causation process for mesothelioma, even if those facts do not themselves establish legal (substantial factor) causation. In this case, while Dr. Frank clearly testified that every exposure to asbestos cumulatively contributed to Rost‘s development of mesothelioma, he
never testified that every exposure to asbestos was a “substantial factor” in contracting the disease. Instead, by way of, inter alia, the lengthy hypothetical that detailed the entirety of Rost‘s exposure to asbestos-containing Ford products while at Smith Motors, Dr. Frank testified that Rost‘s actual exposures to asbestos at Smith Motors over three months was substantially causative of his mesothelioma. . . . . In other words, Dr. Frank did not testify that a single breath of asbestos while at Smith Motors caused Rost‘s mesothelioma, but rather that the entirety of his exposures during the three months he worked there caused his disease. In this regard, Dr. Frank stressed that, unlike with some other asbestos-related diseases (e.g., asbestosis), mesothelioma may develop after only relatively small exposures.
Id. at 1045–46.16 Rost is particularly persuasive given that Dr. Frank testified in that case and his testimony was similar to his testimony in the present case. Moreover,
the other expert testimony on medical causation, including the application of scientific standards to Dale‘s occupational exposure history, was compelling.
Appellants assert that Respondents’ distinction between the each and every exposure theory and the cumulative dose theory is artificial. They also assert that the presentation of the cumulative dose theory conflicts with the Henderson/Lohrmann substantial factor standard. We disagree with both assertions. Stating that a certain exposure contributes to an individual‘s cumulative dose does not espouse
information essential for the jury‘s understanding of medical causation, which must be based on science. We do not interpret this presentation as an attempt to supplant the Henderson/Lohrmann test.
In determining the relative contribution of any exposures to asbestos above background levels, it is important to consider a number of factors, including: the nature of exposure, the level of exposure and the duration of exposure, whether a product gives off respirable asbestos fibers, the level of exposure, whether a person was close to or far from the source of fiber release, how frequently the exposure took place and how long the exposure lasted, whether engineering or other methods of dust control were in place, and whether respiratory protection was used.
(emphases added). Likewise, the factors on which Dr. Maddox relied in forming his opinion overlap with the Henderson factors as they included how the exposure levels were measured, the standard that the exposure should be repetitive, dose response, and the exposures falling within a reasonable latency period.
qualified by the term “contributing” and, therefore, his response as a whole conveyed to the jury the mere contribution of Dale‘s exposure to this particular product to his cumulative dose. We decline to associate this isolated reference to the term “substantial” with either an adoption of the each and every exposure theory or a rejection of the legal requirement that a plaintiff‘s exposure to a particular defendant‘s product must be frequent, especially given Dr. Frank‘s previous statements in his affidavit that his opinions were medical and scientific and that he was not offering opinions about whether an exposure is substantial within the meaning of the law.
Appellants next argue that in addition to their valves, valves made by ten additional manufacturers were located where Dale worked and this decreased the likelihood that their own products caused Dale‘s mesothelioma. Yet, this argument is based on the faulty premise that a “but-for” standard of causation applies to mesothelioma cases when all Lohrmann requires is substantial causation shown by frequent, regular, and proximate exposure to the defendant‘s products. See Henderson, 373 S.C. at 185, 644 S.E.2d at 727 (“In determining whether exposure is actionable, we adopt the ‘frequency, regularity, and proximity test’ set forth in Lohrmann v. Pittsburgh Corning Corp., 782 F.2d 1156, 1162[–63] (4th Cir. 1986): ‘To support a reasonable inference of substantial causation from circumstantial evidence, there must be evidence of exposure to a specific product on a regular basis over some extended period of time in proximity to where the plaintiff actually worked.‘” (emphases added)); Asbestos Litigation, 131 HARV. L. REV. at 662 (analyzing an unpublished opinion of the United States District Court, District of South Carolina, and stating “although the court wrapped its conclusion in substantial factor language, it applied the but-for standard of specific causality—the same standard whose evidentiary difficulties elicited modifications of the test in the first place“).
The substantial factor test formulated in Lohrmann merely requires a plaintiff to show “more than a casual or minimum contact with the product” of the defendant rather than a comparison of these exposures to the exposures to other defendants’ products. 782 F.2d at 1162; see also Rost, 151 A.3d at 1050–51 (“[I]n asbestos products liability cases, evidence of ‘frequent, regular, and proximate’ exposures to the defendant‘s product creates a question of fact for the jury to decide. This [c]ourt has never insisted that a plaintiff must exclude every other possible cause for his or her injury, and in fact, we have consistently held that multiple substantial causes may combine and cooperate to produce the resulting harm to the plaintiff.” (emphases added) (footnote omitted) (citation omitted)).
Based on the foregoing, we reject Appellants’ argument that Respondents’ evidence of substantial causation was insufficient. See Duckett ex rel. Duckett v. Payne, 279 S.C. 94, 96, 302 S.E.2d 342, 343 (1983) (“[T]he appellant carries the burden of convincing this [c]ourt that the [circuit] court erred.“); see also Curcio, 355 S.C. at 320, 585 S.E.2d at 274 (“In considering a JNOV, the [circuit court] is concerned with the existence of evidence, not its weight.“); id. (“The jury‘s verdict must be upheld unless no evidence reasonably supports the jury‘s findings.“); Williams Carpet Contractors, 400 S.C. at 325, 734 S.E.2d at 180 (“When ruling on a JNOV motion, the [circuit] court is required to view the evidence and the inferences that reasonably can be drawn therefrom in the light most favorable to the nonmoving party.“); id. (“This court must follow the same standard.“); id. (“If more than one reasonable inference can be drawn or if the inferences to be drawn from the
To the extent Appellants challenge the admissibility of Respondents’ experts’ testimony on the ground that it was unreliable,18 they have failed to show any significant part of the testimony that could be reasonably characterized as espousing the “each and every exposure” theory. Further, the cumulative dose theory on which Respondents’ experts relied easily meets the standard for reliability set forth in State v. Council, 335 S.C. 1, 515 S.E.2d 508 (1999). See id. at 20, 515 S.E.2d at 518 (“[T]he proper analysis for determining admissibility of scientific evidence is now under the SCRE. When admitting scientific evidence under Rule 702, SCRE, the [circuit court] must find the evidence will assist the trier of fact, the expert witness is qualified, and the underlying science is reliable.“); id. at 19, 515 S.E.2d at 517 (setting forth four of “several factors” a court should examine in considering the admissibility of scientific evidence: “(1) the publications and peer review of the technique; (2) prior application of the method to the type of evidence involved in the case; (3) the
As to items (1) and (2) of the Council factors, Dr. Frank‘s affidavit indicates that scientists have analyzed cumulative asbestos exposure in order to ascribe causation in numerous peer-reviewed, published epidemiological studies, case series, and case reports. These publications “reinforce the scientific consensus that each occupational and para-occupational exposure to asbestos contributes to the cumulative lifetime asbestos exposure and increases a person‘s risk of developing mesothelioma.” (emphasis added). As to item (3), Dr. Frank and his peers have not limited their analyses to the epidemiology of a substance but have also considered other scientific data, such as genetics, host factors, immunologic status, the relationship between risk and the level of exposure, and the dose-response principle. He stated,
It is precisely because scientists and physicians understand the limitations of epidemiology and how certain factors can bias studies toward a lack of statistical significance or finding of a point estimate of no increased risk[] that we look at the epidemiology of a substance along with the other scientific data described above. Each epidemiological study must be evaluated for its strengths and weaknesses, and decisions about cause and effect should only be made on reliable data.
(emphasis added).
As to item (4), Dr. Frank stated that he follows the same weight-of-the-evidence methodology used by the International Agency for Research on Cancer, the World Health Organization, the National Institute for Occupational Safety and Health, and the Agency for Toxic Substances and Disease Registries in reaching his conclusions about the health effects of asbestos. He explained that the duties of these organizations are to evaluate the science and not to set policy. He also explained how the cumulative dose theory is consistent with the classic dose-response principle but noted that occupational and environmental epidemiology “is a blunt instrument and is not, in most cases, well suited to examining precise dose-response relationships.” (emphasis added). Again, Dr. Frank‘s
causation of sentinel diseases like mesothelioma[,]19 the scientific community recognizes case reports and case series reports are useful and valid tools.
Moreover, Appellants have also failed to show there is a reasonable probability the jury‘s verdict was influenced by any testimony that could be reasonably characterized as espousing the each and every exposure theory. See Fields v. Reg‘l Med. Ctr. Orangeburg, 363 S.C. 19, 26, 609 S.E.2d 506, 509 (2005) (“To warrant reversal based on the admission or exclusion of evidence, the appellant must prove both the error of the ruling and the resulting prejudice, i.e., that there is a reasonable probability the jury‘s verdict was influenced by the challenged evidence or the lack thereof.“); id. at 31-34, 609 S.E.2d at 512-13 (holding the court of appeals erred in concluding the plaintiff showed prejudice from the exclusion of certain testimony because the plaintiff did not show a reasonable probability the jury was influenced by the exclusion). Nothing in the testimony of Respondents’ experts indicates they were seeking to substitute their opinions on the science underlying mesothelioma for the legal standard on causation. To the contrary, Dr. Frank‘s affidavit explicitly stated that his opinions were his “medical and scientific opinions” and that he was “not offering legal opinions about whether an exposure is ‘significant’ or ‘substantial’ within the meaning of the law.”
With the clear guidance from the circuit court‘s instructions on the law, which included the Henderson/Lohrmann standard, the jury was capable of distinguishing between the science-based testimony concerning medical causation and the legal standard for establishing causation in the face of multiple possible sources of the plaintiff‘s exposure. Therefore, the presence of any questionable language in isolated portions of the expert testimony paled in comparison to Dale‘s testimony and his experts’ response to specific fact-based hypothetical questions. See supra.
Based on the foregoing, the circuit court acted well within its discretion in admitting the experts’ testimony into evidence.
B. Failure to Warn
As an additional ground for challenging the circuit court‘s denial of their JNOV motion, Appellants assert Respondents failed to meet their burden of proof on their failure-to-warn claims because (1) Appellants were protected by the sophisticated intermediary doctrine and (2) the danger of asbestos gaskets was open and obvious. We will address these two grounds in turn, but first we address Appellants’ interjection of the burden of proof into their assignment of error. “In considering a JNOV, the [circuit court] is concerned with the existence of evidence, not its weight.” Curcio, 355 S.C. at 320, 585 S.E.2d at 274. “The jury‘s verdict must be upheld unless no evidence reasonably supports the jury‘s findings.” Id. In other words, neither the circuit court nor this court may re-weigh the evidence in determining whether it is necessary to set aside a jury‘s verdict.
We will now address Appellants’ two grounds for challenging the jury‘s verdict on Respondents’ failure-to-warn claims.
Reasonable Reliance/Sophisticated Intermediary Doctrine
This court first adopted the sophisticated intermediary doctrine in Bragg v. Hi-Ranger, Inc. when it upheld the following jury instruction given by the circuit court:
[A] manufacturer has no duty to warn of potential risks or dangers inherent in a product if the product is distributed to what we call a learned intermediary or distributed to a sophisticated user who might be in a position to understand and assess the risks involved, and to inform the ultimate user of the risks, and to, thereby, warn the ultimate user of any alleged inherent dangers involved in the product. Simply stated, the sophisticated user defense is permitted in cases involving an employer who was aware of the inherent dangers of a product which . . . the employer purchased for use in his business. Such an employer has a duty to warn his employees of the dangers of the product.
319 S.C. 531, 549, 462 S.E.2d 321, 331-32 (Ct. App. 1995). This court concluded that the circuit court correctly charged the jury and the charge “was an accurate recitation of the law.” Id. at 551, 462 S.E.2d at 332.
“The [sophisticated intermediary] doctrine originated in the Restatement Second of Torts, section 388, comment n, . . . which addresses when warnings to a party in the supply chain are sufficient to satisfy the supplier‘s duty to warn.” Webb v. Special Elec. Co., 370 P.3d 1022, 1033 (Cal. 2016). “The Restatement drafters’ most recent articulation of the sophisticated intermediary doctrine appears in the Restatement Third of Torts, Products Liability, section 2, comment i, at page 30. The drafters intended this comment to be substantively the same as section 388, comment n, of the Restatement Second of Torts.” Webb, 370 P.3d at 1034. Comment i states, in pertinent part:
There is no general rule as to whether one supplying a product for the use of others through an intermediary has a duty to warn the ultimate product user directly or may rely on the intermediary to relay warnings. The standard is one of reasonableness in the circumstances. Among the factors to be considered are the gravity of the risks posed by the product, the likelihood that the intermediary will convey the information to the ultimate user, and the feasibility and effectiveness of giving a warning directly to the user.
Restatement (Third) of Torts: Prods. Liab. § 2, cmt. i (Am. Law. Inst. 1998) (emphases added).
Appellants contend they reasonably relied on Duke to comply with occupational safety laws, citing Dr. Frank‘s testimony admitting that OSHA regulations in effect from 1980 to 1984 permitted a certain level of asbestos exposure in the workplace. Appellants also cite to the OSHA regulation requiring employers to take certain precautions when an employee will be exposed to asbestos dust. However, it is not enough to show that the supplier‘s reliance would have been reasonable—the supplier must also show that it actually relied on the intermediary to convey warnings to end users. See Webb, 370 P.3d at 1036 (“To establish a defense under the sophisticated intermediary doctrine, a product supplier must show not only that it warned or sold to a knowledgeable intermediary, but also that it actually and reasonably relied on the intermediary to convey warnings to end users. This inquiry will typically raise questions of fact for the jury to resolve unless critical facts establishing reasonableness are undisputed.” (emphasis added)).
Here, Fisher‘s corporate representative testified that the reason Fisher did not warn anyone about the dangers of asbestos gaskets was because the company did not consider them to be a health risk. Crosby‘s corporate representative also indicated that Crosby did not consider the gaskets in their valves to be dangerous. This belies Appellants’ claims that they relied on Duke to warn Dale of the dangers of asbestos gaskets. Therefore, the circuit court properly left within the province of the jury the question of whether Appellants actually relied on Duke to warn Dale about their gaskets. See Webb, 370 P.3d at 1036 (stating that a product supplier “must show not only that it warned or sold to a knowledgeable intermediary, but also that it actually and reasonably relied on the intermediary
Appellants also maintain that Duke actually warned its employees of the dangers of asbestos. However, the evidence indicates that when Dale worked as a mechanical inspector, Duke distinguished between asbestos insulation and asbestos gaskets and considered the latter to be harmless. See supra n.22. It was not until the late 1980s or early 1990s that Duke began warning its employees of the dangers of dust from asbestos gaskets. By then, Duke instructed its employees to wear a respirator or mask and to spray down a gasket with water before removing it from a flange.
Finally, Appellants contend they could not have reasonably warned Dale of the danger associated with their gaskets because Dale would not have seen any warning labels on the gaskets when his co-workers began grinding them up. However, Dale would have seen a warning on a replacement gasket when verifying the number on that gasket. This would have alerted him to the need to take precautions during future gasket removals. Further, Appellants do not address the feasibility of placing a warning on the outside of the valve.
Moreover, on appeal, it is Appellants’ burden to convince this court that the circuit court erred in upholding the jury‘s verdict as to this defense. See Duckett v. Payne, 279 S.C. 94, 96, 302 S.E.2d 342, 343 (1983). Because Appellants themselves have not shown that a warning on the outside of the valve would have been ineffective or infeasible, we reject their argument that they could not have reasonably warned Duke employees of the danger associated with their gaskets.
Based on the foregoing, the circuit court properly upheld the jury‘s verdict as to the sophisticated intermediary doctrine.
Open and Obvious Danger
Next, Appellants assert that the danger of asbestos gaskets was open and obvious and Dale admitted he knew asbestos was dangerous. Therefore, Appellants argue, they were entitled to a JNOV on Respondents’ failure-to-warn claims. We disagree.
Appellants rely on Moore v. Barony House Rest., LLC, 382 S.C. 35, 41-42, 674 S.E.2d 500, 504 (Ct. App. 2009) for the proposition that a seller has no duty to warn of an “open and obvious” danger created by its products or a danger that the product‘s users generally recognize. However, “[w]hen reasonable minds may differ as to whether the risk was obvious or generally known, the issue is to be decided by the trier of fact.” Restatement (Third) of Torts: Prods. Liab. § 2, cmt. j (1998). Here, the record shows that during Dale‘s employment as a mechanical inspector, Duke distinguished between asbestos insulation, which it warned employees about, and asbestos
There is no evidence that any safety information about asbestos gaskets was provided to any employees before safety course instructors received a teaching guide in September 1984, nearly four years after Dale first became a mechanical inspector, and that information merely stated that asbestos gaskets produced virtually no dust. According to David Taylor, Duke did not warn employees about the danger associated with asbestos gaskets until the late 1980s or early 1990s, after Dale was no longer a mechanical inspector. Taylor testified that by the late 1980s, Duke required employees involved with the removal of gaskets from valves to wear a respirator and to wet the gasket before removal to minimize the liberation of the dust. Taylor also testified that the only way a typical employee could know that a particular gasket he or she was working with was made of asbestos was if its packaging had been labeled as containing asbestos. Therefore, a reasonable juror could have inferred that the danger associated with the removal of asbestos gaskets from valves was one that was not obvious to Dale or generally recognized by other Duke employees involved with that process before the late 1980s.
We acknowledge Dale‘s testimony that his training as a mechanical inspector included distinguishing asbestos gaskets from other types of gaskets and that he could see the dust produced by the removal of certain gaskets from valves. Thus, a juror could draw a reasonable inference that Dale was aware of some health risk posed by the dust generated when a co-worker removed an asbestos gasket from a valve. Yet, in the light most favorable to Dale, an equally reasonable inference from the evidence is that Dale had no clear or timely warning that his proximity to the removal of gaskets from Appellants’ valves would cause him to develop mesothelioma. Dale testified that Duke had designated “respirator zones” that employees were prohibited from entering without a respirator, employees
Appellants also argue the only reasonable inferences from the evidence are that Dale did not heed Duke‘s warnings about asbestos and, therefore, would not have heeded a warning from Appellants. Appellants contend that Dale “made clear during his testimony that he knew about the hazards of asbestos . . . and that he in fact did not heed warnings from Duke and continued to work around Fisher and Crosby valves despite his knowledge of the alleged hazards.” We disagree with Appellants’ characterization of the testimony in question. That testimony is consistent with the other evidence indicating that from 1980 to 1984, Duke did not warn its employees of the dangers of asbestos gaskets. See supra. Further, we do not interpret the testimony as an admission that Dale knowingly placed himself within proximity of dust from asbestos insulation. Finally, even if the testimony, combined with the other testimony concerning Dale‘s training, would allow a reasonable juror to infer that Dale did not heed Duke‘s warning about asbestos in general, this is not the only reasonable inference.
Based on the foregoing, the circuit court properly upheld the jury‘s verdict on Respondents’ failure-to-warn claims. See Restatement (Third) of Torts: Prods. Liab. § 2, cmt. j (“When reasonable minds may differ as to whether the risk was obvious or generally known, the issue is to be decided by the trier of fact.“).
C. Design Defect
Next, Appellants assert there was no evidence of a reasonable alternative design for the asbestos gaskets used in their valves and, thus, they were entitled to a JNOV on Respondents’ negligence and implied warranty claims. We disagree.
“A product can be defective because of a flaw in its design.” Madden v. Cox, 284 S.C. 574, 579, 328 S.E.2d 108, 112 (Ct. App. 1985). “Liability for a design defect may be based on negligence, strict tort, or warranty.” Id. “In an action based on strict tort or warranty, plaintiff‘s case is complete when he has proved the product, as designed, was in a defective condition unreasonably dangerous to the user when it left the control of the defendant, and the defect caused his injuries.” Id. at 579-80, 328 S.E.2d at 112 (emphasis added). “Liability for negligence requires, in addition to the above, proof that the manufacturer breached its duty to exercise reasonable care to adopt a safe design.” Id. at 580, 328 S.E.2d at 112. “This burden may be met by showing that the manufacturer was aware of the danger and failed to take reasonable steps to correct it.” Id.
In analyzing design defect claims, South Carolina courts apply the “risk-utility” test, which weighs the danger associated with the product‘s use against its utility. See Bragg, 319 S.C. at 543, 462 S.E.2d at 328 (“[A] product is unreasonably dangerous and defective if the danger associated with the use of the product outweighs the utility of the product.“); id. at 544, 462 S.E.2d at 328 (“[I]n South Carolina[,] we balance the utility of the risk inherent in the design of the product with the magnitude of the risk to determine the reasonableness of the manufacturer‘s action in designing the product.“). In Branham v. Ford Motor Company, our supreme court refined the risk-utility test to incorporate the American Law Institute‘s most recent definition of a design defect:
A product . . . is defective in design when the foreseeable risks of harm posed by the product could have been reduced or avoided by the adoption of a reasonable alternative design by the seller or other distributor, or a predecessor in the commercial chain of distribution, and the omission of the alternative design renders the product not reasonably safe.
390 S.C. 203, 223-24, 701 S.E.2d 5, 16 (2010) (emphasis added) (quoting Restatement (Third) of Torts: Prods. Liab. § 2(b) (1998)). Based on this definition, the court set forth the following framework for a plaintiff seeking to establish a design defect claim:
[I]n a product liability design defect action, the plaintiff must present evidence of a reasonable alternative design. The plaintiff will be required to point to a design flaw in the
product and show how his alternative design would have prevented the product from being unreasonably dangerous. This presentation of an alternative design must include consideration of the costs, safety and functionality associated with the alternative design.
Id. at 225, 701 S.E.2d at 16. In other words,
[t]he analysis asks the trier of fact to determine whether the potential increased price of the product (if any), the potential decrease in the functioning (or utility) of the product (if any), and the potential increase in other safety concerns (if any) associated with the proffered alternative design are worth the benefits that will inhere in the proposed alternative design.
Id. n.16. “The state of the art and industry standards are relevant to show . . . the reasonableness of the design . . . .” Bragg, 319 S.C. at 543, 462 S.E.2d at 328.
Here, the circuit court concluded that the evidence created a fact issue for the jury as to the existence of a reasonable alternative design. We agree. We acknowledge that the record shows Duke used the safety valves it purchased from Appellants for high-pressure, high-heat applications—the temperature exceeded 1,000 degrees, and the pressure was approximately 1,200 pounds per square inch. If these valves were not working correctly, the connecting lines could explode, endangering any nearby persons. Asbestos, as opposed to other substances such as fiberglass, rubber, cork, or vegetable fibers, could safely stand up to the extreme conditions of temperature and pressure. An asbestos gasket was one of the best-performing gaskets for these conditions. Dale, who had been trained in the types of gaskets that could be used in various temperature and pressure settings, explained that a rubber gasket would melt at 1,200 degrees.
On the other hand, Fisher‘s corporate representative, Ronald Dumistra, admitted that Fisher had non-asbestos gaskets available for its customers. Dumistra also admitted that for high-pressure, high-temperature applications, a metal gasket could have been used. Therefore, a metal gasket was a candidate for the jury‘s consideration of a reasonable alternative design, given that Dumistra seemed to consider its functionality and safety to be equivalent to that of asbestos gaskets.
Therefore, the circuit court properly concluded that the evidence created a fact issue for the jury. See Gastineau v. Murphy, 331 S.C. 565, 568, 503 S.E.2d 711, 713 (Ct. App. 1998) (holding that a motion for a JNOV “may be granted only if no reasonable jury could have reached the challenged verdict.“).
D. Deviation from Standard of Care
Next, Appellants argue they are entitled to a JNOV on Respondents’ negligence claim because they did not present any evidence of the applicable standard of care or Appellants’ deviation from such a standard. Specifically, Appellants assert that (1) Respondents’ citation of government regulations was not sufficient evidence of the standard of care; and (2) Respondents did not present evidence of a reasonable alternative design and, therefore, failed to establish that Appellants deviated from any applicable standard of care. We disagree.
Further, Dr. Frank indicated Appellants were on notice of the dangers of asbestos and, thus, could have advised Duke to caution employees that if they were going to liberate dust from the asbestos gaskets in Appellants’ valves, they needed to do so in a manner that would reduce their exposure. Dr. Frank explained that when an asbestos gasket is new, it is encapsulated, but after normal use of the product, it deteriorates. Dr. Frank further explained that as the asbestos gasket
Appellants’ corporate representatives admitted that when Dale worked as a mechanical inspector, Appellants never provided any warnings to their customers or users, they never applied warning labels to their products, and they did not conduct any testing to determine whether maintenance activities would liberate asbestos fibers into the air. Further, the evidence and the reasonable inferences from that evidence show that Appellants’ use of metal gaskets in their valves would have been a reasonable alternative to their use of asbestos gaskets. See supra.
Based on the foregoing, Respondents presented sufficient evidence of both the standard of care and Appellants’ deviation from that standard.
II. Additur
Appellants challenge the circuit court‘s granting of Respondents’ motion for a new trial nisi additur on the ground that the court based its ruling on speculation and did not articulate compelling reasons for increasing the damages awards. We disagree.
“When the verdict indicates that the jury was unduly liberal or conservative in its view of the damages, the [circuit court] alone has the power to [alter] the verdict by the granting of a new trial nisi.” Riley v. Ford Motor Co., 414 S.C. 185, 192, 777 S.E.2d 824, 828 (2015) (quoting Allstate Ins. Co. v. Durham, 314 S.C. 529, 531, 431 S.E.2d 557, 558 (1993)). “The consideration of a motion for a new trial nisi additur requires the [circuit court] to consider the adequacy of the verdict in light of the evidence presented.” Vinson v. Hartley, 324 S.C. 389, 405, 477 S.E.2d 715, 723 (Ct. App. 1996). Motions for a new trial nisi “are addressed to the sound discretion of the [circuit court].” Riley, 414 S.C. at 192, 777 S.E.2d at 828 (quoting Graham v. Whitaker, 282 S.C. 393, 401, 321 S.E.2d 40, 45 (1984)). However, the circuit court‘s exercise of discretion
“The [circuit court] who heard the evidence and is more familiar with the evidentiary atmosphere at trial possesses a better-informed view of the damages than this [c]ourt.” Vinson, 324 S.C. at 405, 477 S.E.2d at 723. “Accordingly, great deference is given to the [circuit court].” Id. at 406, 477 S.E.2d at 723 (emphasis added); see also Riley, 414 S.C. at 194, 777 S.E.2d at 829 (“[T]he court of appeals ignored the applicable abuse-of-discretion standard of review, instead focusing its inquiry on a de novo evaluation of whether, in its view, there was sufficient justification for ‘invading the jury‘s province.’ This was error.“). But see Todd v. Joyner, 385 S.C. 509, 517, 685 S.E.2d 613, 618 (Ct. App. 2008) (per curiam) (“‘While the granting of such a motion rests within the sound discretion of the [circuit] court, substantial deference must be afforded to the jury‘s determination of damages.’ To this end, the [circuit] court must offer compelling reasons for invading the jury‘s province by granting a motion for additur.” (emphasis added) (citation omitted) (quoting Green v. Fritz, 356 S.C. 566, 570, 590 S.E.2d 39, 41 (Ct. App. 2003))), aff‘d, 385 S.C. 421, 685 S.E.2d 595 (2009).24
Here, the jury awarded $200,000 in compensatory damages to Dale and $100,000 to Brenda for loss of consortium. The
Appellants also maintain that “parsing” a verdict is prohibited in the absence of a special verdict form. In support of this proposition, Appellants cite to Jenkins v. Few, 391 S.C. 209, 705 S.E.2d 457 (Ct. App. 2010) and Moore v. Moore, 360 S.C. 241, 257, 599 S.E.2d 467, 475 (Ct. App. 2004). In Jenkins, the appellant argued that the circuit court “erred in declining to reduce the jury‘s award of actual damages for trespass to personal property,” but two other causes of action were also submitted to the jury, and the parties had chosen to use a general verdict form. 391 S.C. at 220-21, 705 S.E.2d at 463. This court stated that it was impossible to determine how the jury allocated damages between the three causes of action and declined to speculate as to the allocation. Id. at 221, 705 S.E.2d at 463. Therefore, the court left the circuit court‘s ruling undisturbed. Id.
In Moore, the appellant argued that the circuit court should not have submitted a breach of fiduciary duty claim to the jury because the respondent did not prove damages with reasonable certainty. 360 S.C. at 253, 599 S.E.2d at 473. This court noted that more than one measure of damages was available for breach of fiduciary duty and concluded that without a special verdict form to determine whether the damages were for lost profit or some other measure, the court would have to engage in speculation to address the appellant‘s assignment of error. Id. at 256-57, 599 S.E.2d at 475. Declining to do so, the court upheld the circuit court‘s submission of the claim to the jury. Id. at 257, 599 S.E.2d at 475.
In the present case, we do not view the circuit court‘s observation about the jury‘s award of medical costs as speculative. See Speculate, Merriam-Webster Dictionary, https://www.merriam-webster.com/dictionary/speculate (last visited August 25, 2021) (defining “speculate” as “to take to be true on the basis of insufficient evidence“). Rather, the observation was based on Dr. Frank‘s testimony that he had seen some of the medical bills and the amount he saw was $142,000. Therefore, the circuit court‘s observation was a reasonable inference from that evidence. Further, it is highly unlikely that the loss of consortium verdict, which was only $100,000, included medical expenses, given the medical bill Dr. Frank saw was for $142,000.
It is more likely that the jury awarded Dale $142,000 for medical expenses and the remainder of the $200,000 ($58,000) for non-economic damages. Cf. Riley, 414 S.C. at 193-95, 777 S.E.2d at 829-30 (observing that the plaintiff presented expert testimony that the decedent‘s family suffered over $228,000 in economic damages; stating that the circuit court “was well aware that the [$300,000] jury verdict included an award of noneconomic damages, yet . . . articulated compelling circumstances that [the circuit court] believed warranted the nisi additur;” and holding that there was no abuse of discretion); Waring, 341 S.C. at 260, 533 S.E.2d at 912 (“As to Johnson‘s claim the jury‘s verdict may have been intended to represent a portion of Waring‘s medical expenses, plus pain and suffering, we find this argument patently untenable. The jury‘s award of exactly the amount of Waring‘s medical expenses, to the penny, is an attempt to reimburse her for those very expenses.“); Williams v. Robertson Gilchrist Const. Co., 301 S.C. 153, 155, 390 S.E.2d 483, 484 (Ct. App. 1990), overruled on other grounds by O‘Neal v. Bowles, 314 S.C. 525, 431 S.E.2d 555 (1993) (concurring in the circuit court‘s conclusion that a damages award in the exact amount of the economic losses as presented by the plaintiff‘s expert economist indicated the jury‘s disregard of testimony concerning a funeral bill and non-economic losses); Jones v. Ingles Supermarkets, Inc., 293 S.C. 490, 494, 361 S.E.2d 775, 777 (Ct. App. 1987), overruled on other grounds by O‘Neal v. Bowles, 314 S.C. 525, 431 S.E.2d 555 (holding the circuit court properly granted a new trial nisi additur based on the jury‘s award matching the exact amount of proven economic loss and failing to award noneconomic damages).
Therefore, unlike the posture of this court in Jenkins and Moore, the circuit court in the present case possessed concrete information from the evidence on which it could base its observation about the jury‘s award of medical costs. See Vinson, 324 S.C. at 405, 477 S.E.2d at 723 (“The consideration of a motion for a new trial nisi additur requires the [circuit court] to consider the adequacy of the verdict in light of the evidence presented.” (emphasis added)); id. (“The [circuit court] who heard the evidence and is more familiar with the evidentiary atmosphere at trial possesses a better-informed view of the damages than this [c]ourt.” (emphases added)).
Moreover, we do not view this particular observation as critical to the circuit court‘s discretionary determination that the jury‘s overall verdict was inadequate. After making its observation about the jury‘s award of medical costs, the circuit court recited the law on all categories of damages applicable to the case and thoroughly summarized the evidence supporting an increased verdict. See infra. The circuit court concluded that the evidence supported damages for medical expenses, pain and suffering, loss of enjoyment of life, mental anguish, and future damages and “[t]he jury‘s award of only $200,000 was not sufficient to make [Dale] whole for the magnitude of his losses.” Cf. Bailey v. Peacock, 318 S.C. 13, 14, 455 S.E.2d 690, 692 (1995) (reversing the circuit court‘s granting of a new trial nisi additur because the circuit court made no finding that the verdict was inadequate). The essence of the circuit court‘s ruling was the inadequacy of the overall verdict in light of the evidence presented at trial. Inconsequential language included in that ruling is not a valid basis for reversal. See Sapp, 402 S.C. at 512, 741 S.E.2d at 571 (“The grant or denial
Appellants also challenge the circuit court‘s respective summaries of the evidence regarding medical expenses, noneconomic damages, and loss of consortium damages. As to medical expenses, Appellants assert that the circuit court‘s reliance on Respondents’ evidence was misplaced because that evidence was speculative. We disagree.
“Generally, in order for damages to be recoverable, the evidence should be such as to enable the court or jury to determine the amount thereof with reasonable certainty or accuracy.” Austin v. Stokes-Craven Holding Corp., 387 S.C. 22, 43, 691 S.E.2d 135, 146 (2010) (emphasis added) (quoting Whisenant v. James Island Corp., 277 S.C. 10, 13, 281 S.E.2d 794, 796 (1981)). Although the amount of damages may not “be left to conjecture, guess or speculation, proof with mathematical certainty of the amount of loss or damage is not required.” Id. Further, “[i]n a personal injury action, the plaintiff must recover for all injuries, past and prospective, which arose and will arise from the defendant‘s tortious activity.” Haltiwanger v. Barr, 258 S.C. 27, 32, 186 S.E.2d 819, 821 (1972) (emphases added) (quoting 22 Am. Jur. Damages § 27). “Thus, recovery must be had for future pain and suffering, and for the reasonable value of medical services and impaired earning capacity, to the extent that these injuries are reasonably certain to result in the future from the injury complained of.” Id. (emphasis added) (quoting 22 Am. Jur. Damages § 27). In
[a] plaintiff in a personal injury action seeking damages for the cost of medical services provided to him as a result of a tortfeasor‘s wrongdoing is entitled to recover the reasonable value of those medical services, not necessarily the amount paid. Although the amount paid may be relevant in determining the reasonable value of those services, the trier of fact must look to a variety of other factors in making such a finding. Among those factors to be considered by the jury are the amount billed to the plaintiff, and the relative market value of those services. Clearly, the amount actually paid for medical services does not alone determine the reasonable value of those medical services. Nor does it limit the finder of fact in making such a determination.
Haselden v. Davis, 353 S.C. 481, 484, 579 S.E.2d 293, 295 (2003) (emphases added) (citations omitted). Notably, the opinion of a medical expert has been held to reliably indicate the reasonable value of past and future medical care when it is based on medical data specific to the plaintiff‘s case. See Koenig v. Johnson, No. 2:18-CV-3599-DCN, 2020 WL 2308305, at *10-12 (D.S.C. May 8, 2020).
In the present case, by the time of trial, Dr. Frank had been a specialist in both internal medicine and occupational medicine for over thirty-seven years and involved in scientific research on the topics of asbestos and mesothelioma for almost fifty years. In addition to his medical degree, he held a doctorate in biomedical sciences. He also taught courses in environmental medicine and biomedical science. He testified that he reviewed Dale‘s medical records, testimony, and medical bills and those bills were in line with costs typically associated with treatment of mesothelioma. Dr. Frank also provided a thorough account of the progression of Dale‘s mesothelioma and his past treatments before assigning a likely cost to all past and future medical costs. Cf. Koenig, 2020 WL 2308305 at *10 (noting the plaintiff‘s expert explained how the plaintiff‘s diagnoses required certain medical treatment); id. at *11 (observing that the expert‘s cost estimates were based on a review of the plaintiff‘s medical record and the expert‘s forty years of experience in rehabilitative medicine and holding the expert‘s experience and education in the field provided a reliable basis for his opinion on the cost of the plaintiff‘s future medical care). Dr. Frank estimated that
Cases like his[,] with the kind of extensive treatment and surgery he‘s had, clearly hundreds of thousands. Cases even go to a million dollars or more. So his would be at the high end, given all the things that he‘s had. Obviously, somebody who comes in, gets diagnosed and dies in a month, their costs are less. He‘s had ongoing care and extensive care for a long period of time. The surgery alone could be hundreds of thousands of dollars. And then with everything else, he would be at the high end of what these kinds of cases cost.
(emphasis added). Dr. Frank further explained that it is likely Dale will die from mesothelioma, and closer to the time of death, the medical interventions and hospitalizations will become more intense and more expensive, such as intravenous feedings and eventually hospice. Appellants’ own expert, Dr. James Crapo, admitted that before Dale‘s death, he would “very likely” have more hospitalizations. Dr. Crapo also admitted that it was likely Dale would eventually need supplemental oxygen and require around-the-clock nursing care. At the time of trial, Dale was undergoing experimental treatment involving immunotherapy as an alternative to the chemotherapy Dale could no longer endure. Dr. Frank confirmed that all of Dale‘s treatments were medically necessary.
Given Dr. Frank‘s thorough review and interpretation of Dale‘s medical data, “viewed through the lens of his extensive and specialized experience, training, and education,” we reject Appellants’ claim that Dr. Frank‘s testimony on the cost of Dale‘s medical care was speculative. Koenig, 2020 WL 2308305 at *10 (declining to exclude the opinions of the plaintiff‘s expert physician regarding the cost of plaintiff‘s future medical care and holding the opinions were reliable because they were based on the expert‘s “interpretation of objective medical data viewed through the lens of his extensive and specialized experience, training, and education“).
Dr. Frank testified, without dispute, that the total cost of [Dale‘s] past and future medical care, from the time of his diagnosis to the time of his death, would reasonably be $1,000,000. This undisputed testimony took into account some of [Dale‘s] past medical bills of $142,000, plus the cost of his surgery that was hundreds of thousands of dollars.
The jury heard evidence that [Dale] is currently undergoing an experimental therapy that requires him to go for treatments and doctor visits several times a week. Experts on both sides agreed that [Dale] would likely die from mesothelioma and that his medical needs would increase as he got sicker and closer to death.
(emphasis in original) (transcript citations omitted).
Appellants characterize the above language as “crediting [Dr.] Frank‘s speculation about medical costs as undisputed evidence that the jury had to believe.” Yet, Appellants have not argued that Dr. Frank was unqualified to testify regarding medical costs. While the jury was not required to believe Dr. Frank‘s testimony,25 the circuit court was not precluded from exercising its discretion to consider this testimony credible. See Vinson, 324 S.C. at 405, 477 S.E.2d at 723 (“The consideration of a motion for a new trial nisi additur requires the [circuit court] to consider the adequacy of the verdict in light of the evidence presented.” (emphasis added)); id. (“The [circuit court] who heard the evidence and is more familiar with the evidentiary atmosphere at trial possesses a better-informed view of the damages than this [c]ourt.” (emphases added)); id. at 406, 477 S.E.2d at 723 (“Accordingly, great deference is given to the [circuit court].” (emphasis added)); Sapp, 402 S.C. at 512, 741 S.E.2d at 571 (“The grant or denial of a motion for a new trial nisi rests within the discretion of the [circuit court] and [its] decision will not be disturbed on appeal unless [its] findings are wholly unsupported by the evidence or the conclusions reached are controlled by error of law.” (emphasis added) (quoting Waring, 341 S.C. at 256, 533 S.E.2d at 910)); see also Riley, 414 S.C. at 194, 777 S.E.2d at 829 (“[T]he court of appeals ignored the applicable abuse-of-discretion standard of review, instead focusing its inquiry on a de novo evaluation of whether, in its view, there was sufficient justification for ‘invading the jury‘s province.’ This was error.“); id. at 192, 777 S.E.2d 824, 828 (“When the verdict indicates that the jury was unduly liberal or conservative in its view of the damages, the [circuit court] alone has the power to [alter] the verdict by the granting of a new trial nisi.” (quoting Durham, 314 S.C. at 531, 431 S.E.2d at 558)). Rather, the circuit court‘s determination that the verdict should adequately reflect Dr. Frank‘s reliable opinion on the enormous past and future expenses of Dale‘s disease serves as a compelling reason to increase the damages award.
As to noneconomic damages, the circuit court first examined awards for pain and suffering in comparable cases. See Lucht v. Youngblood, 266 S.C. 127, 136, 221 S.E.2d 854, 858 (1976) (“The comparison approach is helpful and sometimes forceful, however, each case must be evaluated as an individual one, within the
framework of its distinctive facts.“); Kapuschinsky v. United States, 259 F. Supp. 1, 8 (D.S.C. 1966) (“Admittedly not controlling, but worthy of note are treatments of verdicts from all over this country.“). The circuit court noted, “Damages awards for pain and suffering in comparable mesothelioma cases range from $1.5 million to more than $20 million.” The court cited numerous examples of verdicts within this range being upheld by courts across the country.
The circuit court then summarized in stark detail the evidence presented as to Dale‘s pain and suffering, loss of enjoyment of life, and mental anguish, and this summary is supported by the testimony.26 Cf. Riley, 414 S.C. at 194, 777 S.E.2d at 829 (upholding an additur of $600,000 in a wrongful death action and noting the circuit court gave a thorough recitation of the “uncontested, and emotionally compelling” evidence of economic and noneconomic losses suffered by the decedent‘s family); id. at 194-95, 777 S.E.2d 824, 830 (observing
As to the $100,000 award to Brenda for loss of consortium, the circuit court highlighted Brenda‘s fifty-one-year marriage to Dale, the neglect of her own health to care for Dale, her fear, and her potential future loss of at least ten more years with Dale.
Based on the foregoing, the circuit court acted well within its discretion in granting Respondents’ motion for new trial nisi additur. See Sapp, 402 S.C. at 512, 741 S.E.2d at 571 (“The grant or denial of a motion for a new trial nisi rests within the discretion of the trial [court] and [its] decision will not be disturbed on appeal unless [its] findings are wholly unsupported by the evidence or the conclusions reached are controlled by error of law.” (quoting Waring, 341 S.C. at 256, 533 S.E.2d at 910)).
III. Setoff
Prior to trial, Respondents received $2,270,000 in settlement proceeds from Appellants’ co-defendants. Respondents allocated one-third of the total proceeds ($756,667) to Dale‘s claims; one-third to Brenda‘s claims; and one-third to “the release of future claims.” Appellants contend the circuit court erred by accepting Respondents’ allocation of one-third of the total proceeds to a “future wrongful death claim.” Appellants argue that in addition to the partial setoff the court awarded them for Dale‘s claims ($756,667) against the damages awarded to Dale ($1,580,000), they were entitled to a setoff of the one-third Respondents allocated for future claims. We disagree.
“The right to setoff has existed at common law in South Carolina for over 100 years.” Riley, 414 S.C. at 195, 777 S.E.2d at 830. “Allowing setoff ‘prevents an injured person
When a release or a covenant not to sue or not to enforce judgment is given in good faith to one of two or more persons liable in tort for the same injury or the same wrongful death . . . it does not discharge any of the other tortfeasors from liability for the injury or wrongful death unless its terms so provide, but it reduces the claim against the others to the extent of any amount stipulated by the release or the covenant, or in the amount of the consideration paid for it, whichever is the greater[.]
(emphases added). “Therefore, before entering judgment on a jury verdict, the court must reduce the amount of the verdict to account for any funds previously paid by a settling defendant, so long as the settlement funds were paid to compensate the same plaintiff on a claim for the same injury.” Smith v. Widener, 397 S.C. 468, 471-72, 724 S.E.2d 188, 190 (Ct. App. 2012) (emphases added). In other words, “[a] nonsettling defendant is entitled to credit for the amount paid by another defendant who settles for the same cause of action.” Riley, 414 S.C. at 195, 777 S.E.2d at 830 (emphasis added) (quoting Rutland, 400 S.C. at 216, 734 S.E.2d at 145).
“When the settlement is for the same injury, the nonsettling defendant‘s right to a setoff arises by operation of law.” Smith, 397 S.C. at 472, 724 S.E.2d at 190. “Under this circumstance, ’
Here, upon an in camera review of the releases executed by Respondents in favor of Appellants’ co-defendants, the circuit court verified a settlement amount of $2,270,000. The record does not indicate that the parties to these settlements either agreed to allocate the settlement proceeds among the respective claims released or sought court approval of the agreements. Rather, during a post-trial hearing, Respondents advised the circuit court, “internally, [Respondents] have allocated the [settlement proceeds] as follows: one-third for [Dale‘s] claims; one-third for [Brenda‘s] claims; and one-third for the release of future claims.” The circuit court “confirmed that all future claims related to [Dale‘s] mesothelioma, including wrongful death, were released by [Respondents].” The circuit court then concluded that Respondents’ internal allocation of the settlement proceeds was reasonable and declined to apply a setoff for the amount Respondents allocated to “future claims related to [Dale‘s] mesothelioma, including wrongful death,” because any such future claims for which the settling defendants were released were distinct from the personal injury and loss of consortium claims tried to verdict. See Smith, 397 S.C. at 473, 724 S.E.2d at 191 (“[W]hen the prior settlement involves compensation for a different injury from the one tried to verdict, there is no setoff as a matter of law.“).
Initially, we question whether
Appellants argue that the circuit court should not have accepted Respondents’ allocation of one-third of the settlement proceeds to a future wrongful death claim because “that claim is barred as a matter of law” by Respondents’ execution of the releases. We disagree with the logic of this argument, but we will explain its premise: Although a wrongful death claim is for the benefit of the decedent‘s family,28 South Carolina treats this claim as derivative of the decedent‘s own personal claim during his lifetime. See Estate of Stokes ex rel. Spell v. Pee Dee Family Physicians, L.L.P., 389 S.C. 343, 349, 699 S.E.2d 143, 146 (2010) (holding that a wrongful death claim “lies in the decedent‘s estate only when the decedent possessed the right of recovery at his death“); id. at 347, 699 S.E.2d at 145 (“[I]f the decedent had no claim at his death, the estate has no claim.“). If the decedent settled, or prosecuted to judgment, his personal injury claims against a certain defendant during his lifetime, his heirs or beneficiaries are precluded from bringing a wrongful death claim against that defendant after the decedent‘s death. Id.; see also
Nonetheless, if there is a significant chance that the injury in dispute will cause the plaintiff‘s death before he can complete the prosecution of his personal injury claim, both the personal injury claim and a future wrongful death claim pose genuine risks for a defendant seeking to settle the case until those claims are actually released as part of the settlement. Therefore, we reject Appellants’ assumption that if a settling defendant obtains a release of the personal injury claim, then it is unreasonable for that defendant to also obtain a release of any future wrongful death claim due to its derivative nature. Were this assumption to control how settlement proceeds are allocated, it would allow a non-settling defendant to second-guess the settling defendant‘s choice of the claims for which it will pay the plaintiff to release. Only the settling parties get that choice. Cf. Riley, 414 S.C. at 197, 777 S.E.2d at 831 (“A plaintiff who enters into a settlement with a defendant gains a position of control and acquires leverage in relation to a nonsettling defendant. This posture is reflected in the plaintiff‘s ability to apportion the settlement proceeds in the manner most advantageous to it. Settlements are not designed to benefit nonsettling third parties. They are instead created by the settling parties in the interests of these parties. If the position of a nonsettling defendant is worsened by the terms of a settlement, this is the consequence of a refusal to settle. A defendant who fails to bargain is not rewarded with the privilege of fashioning and ultimately extracting a benefit from the decisions of those who do.” (emphases added) (quoting Lard v. AM/FM Ohio, Inc., 901 N.E.2d 1006, 1019 (Ill. App. 2009))); id. (“Settling parties are naturally going to allocate settlement proceeds in a manner that serves their best interests. That fact alone is insufficient to justify appellate reapportionment for the sole purpose of benefitting [the non-settling defendant].“).
Further, Appellants’ assignment of error does not logically flow from their premise that the wrongful death claim is precluded by the release of the personal injury claim. Should the settling parties effect a simultaneous release of personal injury and future wrongful death claims within the same document, as was done here, the resulting preclusion of a future prosecution of either claim does not affect how the settlement proceeds given in consideration for the release are allocated among these released claims. By way of comparison, no one would doubt that the simultaneous release of a personal representative‘s claims for survival and wrongful death precludes the future prosecution of both claims, yet it is common practice to allocate settlement proceeds among those claims.29 Here, Respondents’ release of all past and future claims against the settling defendants should not affect the allocation of the settlement proceeds among the various claims that were released—the settlement proceeds were the very consideration for Respondents’ release of their claims. It logically follows that those proceeds should be allocated among the claims that were released. Therefore, we reject Appellants’ argument that the circuit court should not have accepted Respondents’ allocation of one-third of the settlement proceeds to “future claims related to [Dale‘s] mesothelioma, including wrongful death,” because “that claim [wrongful death] is barred as a matter of law.”
Appellants also maintain that the settlement amount Respondents allocated to a future wrongful death claim compensates for the same injuries at issue in the present case. They state that wrongful death claims “allow a decedent‘s heirs to pursue the decedent‘s personal injury claims after his or her death.” In making this conclusion, Appellants rely on Burroughs v. Worsham, 352 S.C. 382, 406, 574 S.E.2d 215, 227 (Ct. App. 2002), for the proposition that a wrongful death claim is to compensate the heirs of a decedent, who, if he had survived, could have brought a personal injury action. We do not interpret this proposition as defining the nature of a wrongful death claim or the damages recoverable under such a claim. Rather, it is simply the expression of a prerequisite for the right of the decedent‘s heirs to recover their own damages in a wrongful death action. See supra.
As to personal injuries sustained by the decedent during his lifetime, damages are recoverable through a survival claim should he die before prosecuting a personal injury claim, and it is common for a personal representative of a decedent‘s estate to assert both a survival claim and a wrongful death claim in the same litigation. See
Finally, Appellants maintain that accepting Respondents’ allocation allows them a double recovery because (1) the circuit court instructed the jury that the plaintiff “may recover for those future damages that are reasonably certain to result” and (2) the circuit court invoked Dale‘s expected death in justifying its increase in Dale‘s and Brenda‘s damages awards.
As to the second ground, the circuit court justified its increase in Dale‘s award by recounting the testimony concerning the process of dying and the suffering Dale would experience while dying. Again, these future damages are recoverable by Dale in the present action (or in a survival action had Dale died prior to trial) but not by heirs or beneficiaries in a wrongful death action. See supra. On the other hand, the circuit court justified its increase in Brenda‘s loss of consortium award by describing how Dale‘s mesothelioma had affected Brenda up to the time of trial and noting that Brenda‘s time with Dale would be “cut short by at least ten years.” Nonetheless, this reference to the time with Dale that Brenda could lose overlaps with merely one or two elements out of many for the damages recoverable in a wrongful death action. Further, the loss of consortium award will compensate Brenda only rather than all of Dale‘s heirs or beneficiaries. Therefore, this slight overlap in damages does not rise to the level of a “double recovery.”
In sum, the circuit court‘s refusal to allow a setoff of the settlement proceeds allocated to “future claims related to [Dale‘s] mesothelioma, including wrongful death,” did not result in a double recovery for Respondents. Therefore, we affirm the circuit court‘s setoff ruling. See Riley, 414 S.C. at 195, 777 S.E.2d at 830 (“Allowing setoff ‘prevents an injured person from obtaining a double recovery for the damage he sustained, for it is almost universally held that there can be only one satisfaction for an injury or wrong.‘” (emphasis added) (quoting Rutland, 400 S.C. at 216, 734 S.E.2d at 145)).
Appellants challenge the circuit court‘s denial of their respective motions to quash subpoenas requiring their corporate representatives to appear and testify at trial. They argue (1)
Power to compel
The circuit court conducted a hearing by telephone and orally denied Appellants’ respective motions. Appellants’ corporate representatives appeared and testified at trial, and the circuit court later issued a written order denying their motions to quash. In its order, the circuit court rejected Appellants’ argument that their non-resident status precluded the court from compelling them to send representatives to testify at trial. The court emphasized that Appellants were parties to the case and submitted to the court‘s jurisdiction by making a general appearance and litigating the case to trial.
Appellants now assert that a court “does not gain unlimited subpoena power when a party ‘submits to the jurisdiction’ of the court.” Appellants argue there is no overlap between the doctrines of personal jurisdiction and subpoena power. In support of their argument, Appellants cite Syngenta Crop Prot., Inc. v. Monsanto Co., 908 So.2d 121, 128 (Miss. 2005),
Appellants further argue, “Just as Congress established geographic limits to the federal courts’ subpoena power, see
On timely motion, the court . . . shall quash or modify the subpoena if it:
. . .
(ii) requires a person who is not a party nor an officer, director or managing agent of a party, nor a general partner of a partnership that is a party, to travel more than 50 miles from the county where that person resides, is employed or regularly transacts business in person, except that, subject to the provisions of clause (c)(3)(B)(iii) of this rule, such a person may in order to attend trial be commanded to travel from any such place within the state in which the trial is held[.]
Further, the official note to the 1995 amendment to Rule 45 states, in pertinent part:
Rule 45(c)(3)(A)(ii) and 45(c)(3)(B)(iii) are amended to make clear that a non-party general partner of a partnership that is a party, is treated the same as an officer, director or managing agent of a party for purposes of trial subpoenas. Rule 45(c)(3) provides a non-party, subpoenaed to appear at trial more than fifty miles from the place of service, the opportunity to move to quash the subpoena unless a special showing of need is made and reasonable compensation is provided to the witness.
These special provisions are not available to parties or officers, directors and managing agents of parties. The amendment extends the exclusion to a general partner of a partnership that is a party.
(emphases added). This confirms that the legislature intended for South Carolina circuit courts to have subpoena power over parties to proceedings over which those courts preside.
This is consistent with the broad discretionary power a circuit court must exercise over parties to proceedings before it in order to effectively dispense justice. See Capital City Ins. Co. v. BP Staff, Inc., 382 S.C. 92, 103, 674 S.E.2d 524, 530 (Ct. App. 2009) (“The court has broad discretion in its supervision over the progression and disposition of a circuit court case in the interests of justice and judicial economy.“); S.C. Dep‘t of Highways & Pub. Transp. v. Galbreath, 315 S.C. 82, 85, 431 S.E.2d 625, 628 (Ct. App. 1993) (“The conduct of trial . . . is largely within the [circuit court‘s] sound discretion, the exercise of which will not be disturbed on appeal absent an abuse of that discretion or the commission of legal error that results in prejudice for the appellant.“); cf. Hayden v. 3M Co., 211 So. 3d 528, 532 (La. App. 2017) (“In the same way that Louisiana exercises personal jurisdiction over parties participating in litigation in the state, those parties may, upon the discretion of the court, be compelled to appear in Louisiana for discovery depositions, hearings, and/or trial. For these reasons[,] we reverse the trial court‘s quashing of the subpoenas served through the attorneys of record for the non-domiciliary corporations.“).
Based on the foregoing, we reject Appellants’ argument that the circuit court did not have subpoena power over them.
Validity of service
Next, Appellants contend that service of the subpoenas on their counsel in Charleston was defective because
Here, the circuit court concluded that service of the subpoenas was valid under
The language of
The first 2002 amendment amends Rule 45(b)(1) to permit service of subpoenas by the same method as used to serve a
summons and complaint. First, in addition to in hand service of the subpoena, service on an individual could be made by leaving the subpoena at the person‘s home or usual place of abode with a person of suitable age and discretion then residing there as provided in Rule 4(d)(1). Second, a subpoena could be served on an individual, a corporation, or a partnership by registered or certified mail, return receipt requested and delivery restricted to the addressee under Rule 4(d)(8). In addition, the person or the person‘s attorney may accept service under Rule 4(j).
(emphasis added). Therefore, we reject Appellants’ argument that the attorney‘s acknowledgement of receipt under
As to the application of
We also note that service was valid under either
Service pursuant to this paragraph shall not be the basis for the entry of a default or a judgment by default unless the record contains a delivery record showing the acceptance by the defendant which includes an original signature or electronic image of the signature of the person served. Any such default or judgment by default shall be set aside pursuant to
Rule 55(c) orRule 60(b) if the defendant demonstrates to the court that the delivery receipt was signed by an unauthorized person. If delivery of the process is refused or is returned undelivered, service shall be made as otherwise provided by these rules.
Appellants assert their Charleston counsel was not authorized to accept service of process on their behalf. Appellants claim that
Service shall be made as follows: . . . Upon a corporation or upon a partnership or other unincorporated association which is subject to suit under a common name, by delivering a copy of the summons and complaint to an
officer, a managing or general agent, or to any other agent authorized by appointment or by law to receive service of process and if the agent is one authorized by statute to receive service and the statute so requires, by also mailing a copy to the defendant.
(emphasis added).
S.C.R.C.P. 4(d)(1), like its federal counterpart, Rule 4(d)(1) of the Federal Rules of Civil Procedure, provides for service upon an agent only if authorized by appointment or by law. Federal cases dealing with agency by appointment indicate an actual appointment for the specific purpose of receiving process normally is expected and the mere fact a person may be considered to act as defendant‘s agent for some purpose does not necessarily mean that the person has authority to receive process. The courts must look to the circumstances surrounding the relationship and find authority which is either express or implied from the type of relationship between the defendant and the alleged agent. Claims by one to possess authority to receive process or actual acceptance of process by an alleged agent will not necessarily bind the defendant. There must be evidence the defendant intended to confer such authority.
300 S.C. 411, 414, 389 S.E.2d 297, 298 (Ct. App. 1990) (emphasis added).31
Further, “[e]xacting compliance with the rules is not required to effect service of process.” BB & T v. Taylor, 369 S.C. 548, 552, 633 S.E.2d 501, 503 (2006). “Rather, [the
Based on the foregoing, the circumstances in the present case allow the authority of Appellants’ Charleston counsel to be implied from counsel‘s representation of them in the very litigation for which the subpoena was issued. See Hamilton, 300 S.C. at 414, 389 S.E.2d at 298 (“The courts must look to the circumstances surrounding the relationship and find authority which is either express or implied from the type of relationship between the defendant and the alleged agent.“). Significantly, the circuit court already had personal jurisdiction over Appellants, and their counsel already had a duty to ensure they had notice of the proceedings. See Taylor, 369 S.C. at 552, 633 S.E.2d at 503 (“Exacting compliance with the rules is not required to effect service of process. ‘Rather, [the court must] inquire whether the plaintiff has sufficiently complied with the rules such that the court has personal jurisdiction of the defendant and the defendant has notice of the proceedings.‘” (alteration in original) (emphases added) (citation omitted) (quoting Roche, 318 S.C. at 210, 456 S.E.2d at 899)). Under these circumstances, counsel was authorized by Appellants to accept service of process under either
Based on the foregoing, the circuit court properly denied Appellants’ motion to quash the subpoenas.
CONCLUSION
Accordingly, we affirm the circuit court‘s orders denying Appellants’ motion to quash, denying their JNOV motion,
AFFIRMED.
WILLIAMS and MCDONALD, JJ., concur.
Notes
While scientists working for the asbestos industry and defendants in asbestos product liability lawsuits contend that one can extrapolate a “no adverse effect level” from the existing data and/or that massive potency differences [exist] between hypothetical identical fibers of different types of asbestos, those opinions are outside of the scientific mainstream and have been considered and rejected by independent panels of scientific experts with no bias or agenda, such as [the International Agency for Research on Cancer, the Agency for Toxic Substances and Disease Registries, and the National Institute for Occupational Safety and Health].”(emphasis added).
Counsel then asked if these exposures would include products from General Electric, and Dr. Frank replied, “If they contained asbestos and if he was exposed, yes.” Counsel then asked the same question as to numerous other businesses, one by one, to which Dr. Frank gave the same answer. Dr. Frank took care to clarify this answer part of the way through counsel‘s laundry list, stating, “Again, if he had exposures to such a product containing asbestos, it would have contributed to his cumulative exposure.” It is clear that during this line of questioning, Dr. Frank was indicating Dale‘s collective exposures included products from the businesses mentioned by counsel if they contained asbestos and Dale was exposed to them.
Dr. Frank later stated that Dale‘s exposure to the product of one business would be “the contributing cause.” We view his use of the article “the” as inconsistent with the term “contributing” and, thus, we attribute no significance to his use of this article. Subsequently, when asked about a product from another business, Dr. Frank stated, “If he was exposed to asbestos-containing John Crane packing, it would have been, in my opinion, a substantial contributing cause to his mesothelioma.” Although he included the term “substantial” in this response, it was
The script is consistent with the testimony of Duke employee David Taylor, who indicated that Duke distinguished between asbestos insulation, which it warned employees about when Dale worked as a mechanical inspector, and the asbestos in gaskets, which Duke failed to warn employees about until the late 1980s or early 1990s.Actually, asbestos is used very little in Duke Construction today, mostly to insulate electrical cabinets and pack valves, and it is used in gasket material. Even so, the asbestos in these jobs is bonded, which means it produces virtually no dust.
In the past, however, nonbonded asbestos has been used for insulation throughout the Duke system. So there‘s a good chance asbestos dust is present wherever old insulation is being removed.
A subpoena may command a person to attend a trial, hearing, or deposition only as follows:
(A) within 100 miles of where the person resides, is employed, or regularly transacts business in person; or
(B) within the state where the person resides, is employed, or regularly transacts business in person, if the person
(i) is a party or a party‘s officer; or
(ii) is commanded to attend a trial and would not incur substantial expense.